Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform

February 19, 2026 updated by: Hangzhou Medical College

The Individualized Stepwise Treatment Mode of Adolescent Idiopathic Scoliosis

Spinal cord injury (SCI), leads to functional deficits and complications like neurogenic bladder and deep vein thrombosis, imposing a global annual financial burden. This trial aims to compares Jiaji electroacupuncture (JEA) and scalp electroacupuncture (SEA) in SCI rehabilitation. This randomized controlled trial (RCT) compared JEA and SEA in SCI rehabilitation.

Study Overview

Detailed Description

This study employed a randomized controlled clinical trial method to compare the effects of JEA and SEA interventions on the clinical outcomes of patients with traumatic spinal cord injury (TSCI). The findings revealed that, compared to SEA, JEA intervention demonstrated superior performance in improving patients' ASIA grading, motor function scores, light touch sensation scores, pinprick sensation scores, and modified Barthel index. This indicates that JEA has a significant advantage in promoting the enhancement of ASIA grading, recovery of motor and sensory function scores, and improvement in daily living activities among TSCI patients. The conclusions of this study further substantiate the positive role of JEA in ameliorating motor function, sensory function scores, and daily living conditions in patients with spinal cord injury.

Study Type

Interventional

Enrollment (Estimated)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 311000
        • Recruiting
        • the Affiliated Zhejiang Provincial People's Hospital to Hangzhou Medical College.
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°;
  2. The age range of 12 to 16 years old;
  3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing;
  4. Signed informed consent by the patient or their family.

Exclusion Criteria:

Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Conventional treatment
Experimental: intervention
Using paradigms based on transfer learning and semi-supervised learning, using multiple learning methods, transformer image classification algorithms and other mathematical methods, an early warning model and stepped treatment model for adolescent scoliosis were developed and verified, and a cost-effectiveness analysis was conducted at the same time.
Patients will randomly assigned to routine treatment group (control group) and individualized treatment model group (intervention group). All patients will observed and intervened for 4 months. Patients in the control treatment group will follow the treatment plan in the 2016SOSORT guidelines

Patients will be input into the health management platform. The optimal treatment scheme will be then determined through data calculation and sent to individuals (or their families) or schools for implementation under the guidance of the platform. It is important to note that the specific treatment plan varied from person to person. Patients were observed and intervened for a period of 4 months.

  1. Massage therapy
  2. Posture guidance
  3. Schroeder's gymnastics therapy
  4. Bioelectric stimulation therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Cobb angles
Time Frame: 4 months before the intervention and 4 months after the intervention
X-rays were used to check the number of Cobb angles before and 4 months after the intervention to observe the improvement of scoliosis
4 months before the intervention and 4 months after the intervention
Accuracy of new screening modalities
Time Frame: 4 months before and after the intervention, 4 months after the end of the intervention, and 8 months after the end of the intervention
The new screening method "general examination + forward flexion test + scoliosis measuring instrument" was used for examination, and the data results before and 4 months after intervention were compared with the X-ray examination results to verify its accuracy.
4 months before and after the intervention, 4 months after the end of the intervention, and 8 months after the end of the intervention
Hamilton Depression Volume
Time Frame: 4 months before and after the intervention, 4 months after the end of the intervention, and 8 months after the end of the intervention
Depression status was rated using the Hamilton Depression Rating Scale
4 months before and after the intervention, 4 months after the end of the intervention, and 8 months after the end of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xinyun Dr Li, doctor, hangzhou medical colleage

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Actual)

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 11, 2024

First Submitted That Met QC Criteria

March 11, 2024

First Posted (Actual)

March 18, 2024

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Idiopathic Scoliosis (AIS)

Clinical Trials on Conventional treatment

Subscribe